• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由新冠病毒引起的多器官损伤:充血性(心肺)心力衰竭和血心屏障渗漏。

Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage.

机构信息

Department of Physiology, University of Louisville School of Medicine, Louisville, KY, 40202, USA.

出版信息

Mol Cell Biochem. 2021 Apr;476(4):1891-1895. doi: 10.1007/s11010-021-04054-z. Epub 2021 Jan 22.

DOI:10.1007/s11010-021-04054-z
PMID:33483858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7822399/
Abstract

Corona virus disease-19 (covid-19) is caused by a coronavirus that is also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and is generally characterized by fever, respiratory inflammation, and multi-organ failure in susceptible hosts. One of the first things during inflammation is the response by acute phase proteins coupled with coagulation. The angiotensinogen (a substrate for hypertension) is one such acute phase protein and goes on to explain an association of covid-19 with that of angiotensin-converting enzyme-2 (ACE2, a metallopeptidase). Therefore, it is advisable to administer, and test the efficacy of specific blocker(s) of angiotensinogen such as siRNAs or antibodies to covid-19 subjects. Covid-19 activates neutrophils, macrophages, but decreases T-helper cells activity. The metalloproteinases promote the activation of these inflammatory immune cells, therefore; we surmise that doxycycline (a metalloproteinase inhibitor, and a safer antibiotic) would benefit the covid-19 subjects. Along these lines, an anti-acid has also been suggested for mitigation of the covid-19 complications. Interestingly, there are three primary vegetables (celery, carrot, and long-squash) which are alkaline in their pH-range as compared to many others. Hence, treatment with fresh juice (without any preservative) from these vegies or the antioxidants derived from purple carrot and cabbage together with appropriate anti-coagulants may also help prevent or lessen the detrimental effects of the covid-19 pathological outcomes. These suggested remedies might be included in the list of putative interventions that are currently being investigated towards mitigating the multi-organ damage by Covid-19 during the ongoing pandemic.

摘要

新型冠状病毒病(COVID-19)是由一种冠状病毒引起的,这种冠状病毒也被称为严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2),通常以易感宿主的发热、呼吸道炎症和多器官衰竭为特征。炎症发生的早期反应之一是急性相蛋白与凝血的结合。血管紧张素原(高血压的底物)就是这样一种急性相蛋白,它进一步解释了 COVID-19 与血管紧张素转换酶 2(ACE2,一种金属肽酶)之间的关联。因此,给 COVID-19 患者服用和测试血管紧张素原的特定抑制剂(如 siRNA 或抗体)的疗效是明智的。COVID-19 会激活中性粒细胞、巨噬细胞,但会降低 T 辅助细胞的活性。金属蛋白酶促进这些炎症免疫细胞的激活,因此,我们推测多西环素(一种金属蛋白酶抑制剂,也是一种更安全的抗生素)将有益于 COVID-19 患者。沿着这些思路,也有人建议使用抗酸剂来缓解 COVID-19 的并发症。有趣的是,有三种主要的蔬菜(芹菜、胡萝卜和长南瓜)在其 pH 值范围内呈碱性,而其他许多蔬菜则呈酸性。因此,用这些蔬菜的新鲜汁(不含任何防腐剂)或从紫胡萝卜和卷心菜中提取的抗氧化剂,以及适当的抗凝剂进行治疗,也可能有助于预防或减轻 COVID-19 病理结果的有害影响。这些建议的治疗方法可能会被列入目前正在研究的减轻 COVID-19 在大流行期间对多器官损害的潜在干预措施清单中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc0/7822399/4690a67bf9f1/11010_2021_4054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc0/7822399/4690a67bf9f1/11010_2021_4054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc0/7822399/4690a67bf9f1/11010_2021_4054_Fig1_HTML.jpg

相似文献

1
Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage.由新冠病毒引起的多器官损伤:充血性(心肺)心力衰竭和血心屏障渗漏。
Mol Cell Biochem. 2021 Apr;476(4):1891-1895. doi: 10.1007/s11010-021-04054-z. Epub 2021 Jan 22.
2
Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury.血心屏障渗漏机制:对 COVID-19 引起的心血管损伤的影响。
Int J Mol Sci. 2021 Dec 17;22(24):13546. doi: 10.3390/ijms222413546.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
COVID-19 and cardiovascular diseases.新型冠状病毒肺炎与心血管疾病。
J Mol Cell Biol. 2021 Jul 6;13(3):161-167. doi: 10.1093/jmcb/mjaa064.
5
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.血管紧张素转换酶 2 和肾素血管紧张素系统抑制剂在 COVID-19 中的应用:最新进展。
High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26.
6
Heart failure and COVID-19: synergism of two inflammatory conditions?心力衰竭与 COVID-19:两种炎症状态的协同作用?
Br J Community Nurs. 2021 Jan 2;26(1):18-25. doi: 10.12968/bjcn.2021.26.1.18.
7
DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.DNA 适体掩蔽血管紧张素转化酶 2 作为治疗 SARS-CoV-2 大流行的创新方法。
Pharmacol Res. 2022 Jan;175:105982. doi: 10.1016/j.phrs.2021.105982. Epub 2021 Nov 16.
8
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.以性别为基础评估 COVID-19 感染的影响。
Stem Cell Rev Rep. 2021 Feb;17(1):94-112. doi: 10.1007/s12015-020-10048-z. Epub 2020 Oct 7.
9
What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?在与 COVID-19 的这场战斗中,塞尔吉奥·费雷拉会对你的医生说些什么:激肽释放酶/激肽系统如何?
Med Hypotheses. 2020 Oct;143:109886. doi: 10.1016/j.mehy.2020.109886. Epub 2020 May 30.
10
The Science Underlying COVID-19: Implications for the Cardiovascular System.新型冠状病毒肺炎相关科学:对心血管系统的影响。
Circulation. 2020 Jul 7;142(1):68-78. doi: 10.1161/CIRCULATIONAHA.120.047549. Epub 2020 Apr 15.

引用本文的文献

1
Kidney Stone Disease: Epigenetic Dysregulation in Homocystinuria and Mitochondrial Sulfur Trans-Sulfuration Ablation Driven by COVID-19 Pathophysiology.肾结石疾病:同型胱氨酸尿症中的表观遗传失调以及由新冠病毒病理生理学驱动的线粒体硫转硫化作用消融
Biomolecules. 2025 Aug 14;15(8):1163. doi: 10.3390/biom15081163.
2
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort.COVID-19 mRNA疫苗接种在接种者和突破性感染个体中引发的黏膜和血清中和免疫反应:来自路易斯维尔队列的纵向研究
Vaccines (Basel). 2025 May 24;13(6):559. doi: 10.3390/vaccines13060559.
3

本文引用的文献

1
Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies.用于治疗炎症性肠病的受体介导靶向给药系统:机遇与新策略
Acta Pharm Sin B. 2021 Sep;11(9):2798-2818. doi: 10.1016/j.apsb.2020.11.003. Epub 2020 Nov 7.
2
Venous Thromboembolism in Hospitalized COVID-19 Patients.住院 COVID-19 患者中的静脉血栓栓塞症。
Am J Ther. 2020 Nov/Dec;27(6):e599-e610. doi: 10.1097/MJT.0000000000001295.
3
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.
Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID.
用咪喹莫特刺激免疫以最大程度地减少 SARS-CoV-2 感染并预防长新冠。
Int J Mol Sci. 2024 Jul 12;25(14):7661. doi: 10.3390/ijms25147661.
4
Multi-omic analysis characterizes molecular susceptibility of receptors to SARS-CoV-2 spike protein.多组学分析表征了受体对SARS-CoV-2刺突蛋白的分子易感性。
Comput Struct Biotechnol J. 2023 Nov 10;21:5583-5600. doi: 10.1016/j.csbj.2023.11.012. eCollection 2023.
5
Mining the potential therapeutic targets for COVID-19 infection in patients with severe burn injuries via bioinformatics analysis.通过生物信息学分析挖掘严重烧伤患者 COVID-19 感染的潜在治疗靶点。
Int Wound J. 2023 Sep;20(7):2742-2752. doi: 10.1111/iwj.14151. Epub 2023 Mar 16.
6
COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients.COVID-19 在患者中作为一种急性后期综合征模拟了肌肉萎缩症的肺部功能障碍。
Int J Mol Sci. 2022 Dec 24;24(1):287. doi: 10.3390/ijms24010287.
7
Analysis of potential risk factors associated with COVID-19 and hospitalization.分析与 COVID-19 及住院相关的潜在风险因素。
Front Public Health. 2022 Aug 5;10:921953. doi: 10.3389/fpubh.2022.921953. eCollection 2022.
8
Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers.在基因工程小鼠模型中模拟 COVID-19 症状:对长期患者的影响。
Mol Cell Biochem. 2023 Jan;478(1):103-119. doi: 10.1007/s11010-022-04487-0. Epub 2022 Jun 22.
9
Mechanism of Multi-Organ Injury in Experimental COVID-19 and Its Inhibition by a Small Molecule Peptide.实验性新型冠状病毒肺炎多器官损伤机制及其小分子肽抑制作用
Front Pharmacol. 2022 May 30;13:864798. doi: 10.3389/fphar.2022.864798. eCollection 2022.
10
A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection.关于增强免疫系统措施的综述:预防冠状病毒感染的自然保护模式
Front Immunol. 2022 Mar 15;13:837290. doi: 10.3389/fimmu.2022.837290. eCollection 2022.
COVID-19 重症患者的血栓和出血并发症:一项多中心观察研究。
Crit Care. 2020 Sep 18;24(1):561. doi: 10.1186/s13054-020-03260-3.
4
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).达格列净对心力衰竭预防试验(DAPA-HF)中基线收缩压的影响。
Eur Heart J. 2020 Sep 21;41(36):3402-3418. doi: 10.1093/eurheartj/ehaa496.
5
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.新冠肺炎患者抗凝治疗失败后继发大块肺栓塞采用溶栓及阿加曲班治疗。
Am J Health Syst Pharm. 2020 Nov 16;77(23):1961-1964. doi: 10.1093/ajhp/zxaa287.
6
The journey of remdesivir: from Ebola to COVID-19.瑞德西韦的历程:从埃博拉到新冠病毒。
Drugs Context. 2020 May 22;9. doi: 10.7573/dic.2020-4-14. eCollection 2020.
7
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血:SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
8
Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series.2019 年冠状病毒病大流行期间儿童多系统炎症综合征:病例系列研究。
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):393-398. doi: 10.1093/jpids/piaa069.
9
Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.羟氯喹雾化吸入可能显著减少甚至预防 SARS-CoV-2 感染后的严重临床症状。
Med Hypotheses. 2020 Sep;142:109783. doi: 10.1016/j.mehy.2020.109783. Epub 2020 Apr 27.
10
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的紧急授权。
Ann Pharmacother. 2020 Aug;54(8):827-831. doi: 10.1177/1060028020925558. Epub 2020 May 9.